A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects

NCT00249860 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

257

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Interferon-beta-1a
DRUG: Placebo
DRUG: Ribavirin plus Interferon-beta-1a

Sponsor

EMD Serono

Collaborators

[object Object]